Old North State Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Old North State Trust’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$32K	–	399
2023 Q1	$32K	Hold	100	–	–	0.02%	287
2022 Q4	$29K	Hold	100	–	–	0.02%	286
2022 Q3	$29K	Buy	+100	New	+$28.8K	0.03%	249
2022 Q1	–	Sell	-100	Closed	-$22K	–	319
2021 Q4	$22K	Hold	100	–	–	0.02%	268
2021 Q3	$18K	Hold	100	–	–	0.02%	256
2021 Q2	$20K	Buy	+100	New	+$20.9K	0.02%	267

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Old North State Trust's VRTX Position: Q2 2023 in Review

Old North State Trust sold out of Vertex Pharmaceuticals (VRTX) in Q2 2023, closing a stake of 100 shares — an estimated $32K sold.

Old North State Trust first reported a position in VRTX in Q2 2021 and held it in 6 quarters. The position peaked at $32K in Q1 2023. 1,285 funds tracked by Wall St. Rank hold VRTX as of Q2 2023.

Old North State Trust reported no remaining Vertex Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Old North State Trust sold 100 Vertex Pharmaceuticals shares in Q2 2023, an estimated $32K.
Old North State Trust first reported a position in Vertex Pharmaceuticals in Q2 2021 and held it in 6 quarters.
Old North State Trust's Vertex Pharmaceuticals position peaked at $32K in Q1 2023.
1,285 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2023.

Based on Old North State Trust's 13F filing for Q2 2023, filed 22 Aug 2023.